medigraphic.com
ISSN 1561-2945 (Print)

2012, Number 2

<< Back Next >>

Revista Cubana de Cirugía 2012; 51 (2)

Hepatoid gastric adenocarcinoma

Guerra MJL, Guarnaluce BR

Language: Spanish
References: 33
Page:
PDF size: 74.54 Kb.


ABSTRACT

Hepatoid gastric adenocarcinoma is a malignant tumor having morphology similar to that of the hepatocellulary carcinoma, and some of them have immunoreactive alpha fetoprotein. It is aggressive, lethal and its prognosis is bad. Here is a 84 years-old female patient who suffered hepatoid-type gastric adenocarcinoma. The treatment was subtotal distal gastrectomy plus D2-type lymphadenectomy. The objective of this paper was to present this unusual case and a literature review on this topic.


REFERENCES

  1. Borrman R. Geschwülste des magens. In: von Henke FU, Lurbash O, eds. Handbush der speziellen pathologischen antomie. Berlin: Verlag von Julius Springer; 1926. p. 864-71.

  2. Sobin LH, Wittekind CM. TNM classification of malignant tumours. 6th ed. New York: Wiley-Liss; 2002. p. 178-83.

  3. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma. 2nd. English Edition. Gastric Cancer. 1998;1:10-24.

  4. Bourreille J, Metayer P, Sauger F, Fondimare A. Existence d'alpha fetoproteine au cour d'un cancer secondaire du foie d'origine gastrique. Als Press Med. 1970;78:1277-8.

  5. Ishikura H, Fukasawa Y, Ogasawara K, Natori T, Tsukada Y, Aizawa M. An AFP-producing gastric carcinoma with features of hepatic differentiation: a case report. Cancer. 1985;56:840-8.

  6. Ishikura H, Kirimoto K, Shamoto M, Miyamoto Y, Ymagiwa H, Itho T, Aizawa M. Hepatoid adenocarcinoma of the stomach: an analysis of seven cases. Cancer. 1986;58:119-26.

  7. McIntire KR, Waldmann TA, Moertel CG, Go WLW. Serum alpha-fetoprotein in patients with neoplastic carcinomas. N Engl J Med. 1971;285:1060-1.

  8. Takanahashi Y, Mai O, Ogino T, Ueda H, Sawaguchi K, Ueno M. Clinicopathological study of AFP-producing gastric cancer. Significance of AFP in gastric cancer. J Jpn Surg Soc. 1987;88:696-700.

  9. Mori M, Ambe K, Adachi Y, Yakeishi Y, Nakamura K, Hachitanda Y, et al. Pronostic value of immunohistochemical identified CEA, AFP, and S- Chen, Mi 100 protein positive cells in gastric carcinoma. Cancer. 1988;62:534-40.

  10. Díez Redondo P, Torrego García JC. Carcinoma hepatoide gástrico. Rev Esp Enferm Dig. 2005;97(5):380-1.

  11. Sheng Zhang Wang, Yi-Hui Xue, Yu-Peng Wang. Cerebral metastasis from hepatoid adenocarcinoma of the stomach. World J Gastroenterol. 2007 November 21;13(43):5787-93.

  12. Takanahashi Y, Mai O, Ogino T, Ueda H, Sawaguchi K, Ueno M. Clinicopathological study of AFP-producing gastric cancer. Significance of AFP in gastric cancer. J Jpn Surg Soc. 1987;88:696-700.

  13. Hayashi Y, Takanashi Y, Ohsawa H, Ishii H, Nakatani Y. Hepatoid adenocarcinoma in the lung. Lung Cancer. 2002;38:211-4.

  14. Shih NN, Tsung JS, Yang AH, Tsou MH, Cheng TY. A unique pancreatic tumor with exclusive hepatocytic differentiation. Ann Clin Lab Sci. 2006;36:216-21.

  15. Lazaro J, Rubio D, Repolles M, Capote L. Hepatoid carcinoma of the ovary and management. Acta Obstet Gynecol Scand. 2007;86(4):498-9.

  16. Takeuchi K, Kitazawa S, Hamanishi S, Inagaki M, Murata K. A case of alpha-fetoprotein-producing adenocarcinoma of the endometrium with a hepatoid component as a potential source for alpha-fetoprotein in a postmenopausal woman. Int J Gynecol Cancer. 2006;16:1442-5.

  17. Lopez-Beltran A, Luque RJ, Quintero A, Requena MJ, Montironi R. Hepatoid adenocarcinoma of the urinary bladder. Virchows Arch. 2003 Apr;442(4):381-7.

  18. Vardaman C, Albores-Saavedra J. Clear cell carcinomas of the gallbladder and extrahepatic bile ducts. Am J Surg Pathol. 1995;19:91-9.

  19. Ishikura H, Ishiguro T, Enatsu C, Fujii H, Kakuta Y, Kanda M, et al. Hepatoid adenocarcinoma of the renal pelvis producing alpha-fetoprotein of hepatic type and bile pigment. Cancer. 1991;67:3051-6.

  20. Foschini MP, Baccarini P, Dal Monte PR, Sinard J, Eusebi V, Rosai J. Albumin gene expression in adenocarcinomas with hepatoid differentiation. Virchows Arch. 1998 Dec;433(6):537-41.

  21. Supriatna Y, Kishimoto T, Uno T, Nagai Y, Ishikura H. Evidence for hepatocellular differentiation in alpha-fetoprotein-negative gastric adenocarcinoma with hepatoid morphology: a study with in situ hybridisation for albumin mRNA. Pathology. 2005 Jun;37(3):211-5.

  22. Gálvez-Muñoz E, Gallego-Plazas J, Gonzalez-Orozco V, Menarguez-Pina F, Ruiz-Maciá JA, Morcillo MA. Hepatoid adenocarcinoma of the stomach a different histology for not so different gastric adenocarcinoma: a case report. Int Semin Surg Oncol. 2009;6:13.

  23. Maitra A, Murakata LA, Albores-Saavedra J. Immunoreactivity for hepatocyte paraffin 1 antibody in hepatoid adenocarcinomas of the gastrointestinal tract. Am J Clin Pathol. 2001 May;115(5):689-94.

  24. Iso Y, Sawada T, Shimoda M, Rokkaku K, Ohkura Y, Kubota K. Solitary AFP and PIVKA-II-producing hepatoid gastric cancer with giant lymph node metastasis. Hepatogastroenterology. 2005 Nov-Dec;52(66):1930-2.

  25. Ushiku T, Uozaki H, Shinozaki A, Ota S, Matsuzaka K, Nomura S, et al. Glypican 3-expressing gastric carcinoma: distinct subgroup unifying hepatoid, clear-cell, and alpha-fetoprotein-producing gastric carcinomas. Cancer Sci. 2009 Apr;100(4):626-32.

  26. Kodama T, Kameya T, Hirota T, Shimosato Y, Ohkura H, Mukojima T, et al. Production of alpha-fetoprotein, normal serum proteins, and human chorionic gonadotropin in stomach cancer: histologic and immunohistochemical analyses of 35 cases. Cancer. 1981;48:1647-55.

  27. Kang GH, Kim YI. Alpha-fetoprotein-producing gastric carcinoma presenting focal hepatoid differentiation in metastatic lymph nodes. Virchows Arch. 1998;432:85-7.

  28. Fujii H, Ichikawa K, Takagaki T, Nakanishi Y, Ikegami M, Hirose S, et al. Genetic evolution of á fetoprotein producing gastric cancer. J Clin Pathol. 2003 December;56(12):942-9.

  29. Koide N, Nishio A, Igarashi J, Kajikawa S, Adachi W, Amano J. Alpha-fetoprotein-producing gastric cancer: histochemical analysis of cell proliferation, apoptosis, and angiogenesis. Am J Gastroenterol. 1999;94:1658-63.

  30. Takahashi T, Kochi M, Kanamori N, Kaiga T, Funada T, Fujii M, et al. Complete remission with FLEP chemotherapy for multiple liver metastasis from alpha-fetoprotein-producing gastric cancer--report of a case. Gan To Kagaku Ryoho. 2009 Nov;36(11):1885-8.

  31. Kochi M, Fujii M, Kaiga T, Takahashi T, Morishita Y, Kobayashi M, et al. FLEP chemotherapy for alpha-fetoprotein-producing gastric cancer. Oncology. 2004;66(6):445-9.

  32. Meguro E, Kimura T, Noda Y, Matsumoto Y, Irinoda T, Hayakawa Y, et al. A case of advanced gastric cancer successfully treated with TS-1/CDDP combination chemotherapy, able to maintain CR for more than two years against multiple liver metastases. Gan To Kagaku Ryoho. 2007 Feb;34(2):249-52.

  33. Kakeji Y, Morita M, Maehara Y. Strategies for treating liver metastasis from gastric cancer. Surg Today. 2010 Apr;40(4):287-94.




2020     |     www.medigraphic.com